Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ... Journal of the American college of cardiology 76 (25), 2982-3021, 2020 | 6816* | 2020 |
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS) A Festa, R D’Agostino Jr, G Howard, L Mykkänen, RP Tracy, SM Haffner Circulation 102 (1), 42-47, 2000 | 3714 | 2000 |
Stenting versus endarterectomy for treatment of carotid-artery stenosis TG Brott, RW Hobson, G Howard, GS Roubin, WM Clark, W Brooks, ... New England Journal of Medicine 363 (1), 11-23, 2010 | 3569 | 2010 |
Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association RD Brook, B Franklin, W Cascio, Y Hong, G Howard, M Lipsett, R Luepker, ... Circulation 109 (21), 2655-2671, 2004 | 2835 | 2004 |
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient … J Emberson, KR Lees, P Lyden, L Blackwell, G Albers, E Bluhmki, T Brott, ... The Lancet 384 (9958), 1929-1935, 2014 | 2674 | 2014 |
Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral … LB Goldstein, R Adams, MJ Alberts, LJ Appel, LM Brass, CD Bushnell, ... Stroke 37 (6), 1583-1633, 2006 | 2231 | 2006 |
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes MJ Reeves, CD Bushnell, G Howard, JW Gargano, PW Duncan, G Lynch, ... The Lancet Neurology 7 (10), 915-926, 2008 | 1544 | 2008 |
Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study Northern Manhattan Stroke Study Collaborators, RL Sacco, ... American journal of epidemiology 147 (3), 259-268, 1998 | 1379* | 1998 |
Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes R Malik, G Chauhan, M Traylor, M Sargurupremraj, Y Okada, A Mishra, ... Nature genetics 50 (4), 524-537, 2018 | 1284 | 2018 |
Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study GL Burke, GW Evans, WA Riley, AR Sharrett, G Howard, RW Barnes, ... Stroke 26 (3), 386-391, 1995 | 1260 | 1995 |
Cardiovascular risk factors and cognitive decline in middle-aged adults D Knopman, LL Boland, T Mosley, G Howard, D Liao, M Szklo, ... Neurology 56 (1), 42-48, 2001 | 1227 | 2001 |
The reasons for geographic and racial differences in stroke study: objectives and design VJ Howard, M Cushman, LV Pulley, CR Gomez, RC Go, RJ Prineas, ... Neuroepidemiology 25 (3), 135-143, 2005 | 1171 | 2005 |
Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study G Howard, LE Wagenknecht, GL Burke, A Diez-Roux, GW Evans, ... Jama 279 (2), 119-124, 1998 | 1133 | 1998 |
Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators. G Howard, AR Sharrett, G Heiss, GW Evans, LE Chambless, WA Riley, ... Stroke 24 (9), 1297-1304, 1993 | 1085 | 1993 |
Insulin sensitivity and atherosclerosis G Howard, DH O’Leary, D Zaccaro, S Haffner, M Rewers, R Hamman, ... Circulation 93 (10), 1809-1817, 1996 | 1022 | 1996 |
Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort WD Rosamond, AR Folsom, LE Chambless, CH Wang, PG McGovern, ... Stroke 30 (4), 736-743, 1999 | 1021 | 1999 |
Cardiovascular health in African Americans: a scientific statement from the American Heart Association MR Carnethon, J Pu, G Howard, MA Albert, CAM Anderson, AG Bertoni, ... Circulation 136 (21), e393-e423, 2017 | 923 | 2017 |
Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial JM Gaziano, C Brotons, R Coppolecchia, C Cricelli, H Darius, PB Gorelick, ... The Lancet 392 (10152), 1036-1046, 2018 | 889 | 2018 |
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association DT Lackland, EJ Roccella, AF Deutsch, M Fornage, MG George, ... Stroke 45 (1), 315-353, 2014 | 884 | 2014 |
Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial SPS3 Study Group The Lancet 382 (9891), 507-515, 2013 | 789 | 2013 |